News from anthera pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:ALKS,NASDAQ-NMS:AMLN)

Mar 23, 2015, 16:05 ET

Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it has completed the previously announced underwritten public offering of...

Mar 19, 2015, 15:00 ET

Anthera Announces $3 Million Research Award from Cystic Fibrosis Foundation Therapeutics for Development of Sollpura - a Novel Enzyme Therapy

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced it has received an award from Cystic Fibrosis Foundation Therapeutics Inc. of up to $3...

Mar 18, 2015, 09:01 ET

Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the pricing of an underwritten public offering of 5,555,556 shares of its common...

Mar 17, 2015, 16:06 ET

Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced that it intends to offer and sell shares of its common stock in an underwritten...

Mar 16, 2015, 08:44 ET

Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase 3 Trial with Blisibimod for IgA Nephropathy

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), in collaboration with its partner Zenyaku Kogyo Co., Ltd. today announced that the BRIGHT-SC...

Mar 16, 2015, 08:21 ET

Anthera Pharmaceuticals Reports 2014 Fourth Quarter and Fiscal Year Financial Results, Operational Update and Recent Event Highlights

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced financial results and an operational update for the fourth quarter and year ended...

Feb 19, 2015, 13:30 ET

Anthera Pharmaceuticals to Present at Cowen & Co. Healthcare Conference

 Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), announced today that Paul F. Truex, President and Chief Executive Officer, will present a...

Feb 10, 2015, 15:56 ET

Anthera Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

 Anthera Pharmaceuticals (NASDAQ: ANTH) today announced that the company has received formal notification from the Nasdaq Stock Market...

Feb 10, 2015, 08:45 ET

Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase 3 Trial with Blisibimod for Systemic Lupus Erythematosus

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced the successful completion of an interim analysis of its Phase 3 trial (CHABLIS-SC1) of...

Jan 07, 2015, 15:45 ET

Anthera Pharmaceuticals Announces Appointment of Klara A. Dickinson as Senior Vice President, Chief Regulatory Officer

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced the appointment of Klara A. Dickinson as Senior Vice President, Chief Regulatory...

Dec 30, 2014, 14:30 ET

Anthera Pharmaceuticals Announces Lupus Symposium During 2015 JP Morgan Healthcare Conference

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced that it is inviting its shareholders and investors to a symposium on Systemic Lupus...

Dec 15, 2014, 09:00 ET

Anthera Pharmaceuticals Licenses Japan Rights for Blisibimod to Zenyaku Kogyo Co., Ltd.

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) announced today that Anthera and Zenyaku Kogyo Co., Ltd. of Tokyo, Japan executed an...

Nov 23, 2014, 21:30 ET

Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), announced today that Paul F. Truex, President and Chief Executive Officer, will present a corporate...

Nov 20, 2014, 11:00 ET

Anthera and Patheon Sign Manufacturing Agreement for Liprotamase Phase III Registration Trial

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) announced today it has signed a manufacturing and supply agreement with the Patheon®...

Nov 14, 2014, 16:05 ET

Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the third quarter ended September 30,...

Oct 01, 2014, 16:00 ET

Anthera Pharmaceuticals Announces Update on Strategic Partnership Discussions for Blisibimod

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today confirmed it is engaged in potential partnership negotiations for blisibimod for both lupus...

Jul 28, 2014, 17:40 ET

Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the second quarter ended June 30, 2014....

Jul 14, 2014, 16:42 ET

Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced that it has acquired Sollpura (liprotamase), a novel investigational Pancreatic Enzyme...

Jun 23, 2014, 17:00 ET

Anthera Pharmaceuticals Appoints Brian R. Mueller to Board of Directors

 Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...

Jun 13, 2014, 15:30 ET

Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...